Literature DB >> 10932443

Issues and outcomes in integrated treatment programs for dual disorders.

J M Jerrell1, J L Wilson, D C Hiller.   

Abstract

In an integrated, dual disorder treatment program delivered at two sites, the authors address numerous barriers to delivering services to dually diagnosed consumers and employ a set of multidimensional indicators to assess outcome. Consumers who received services through the well-implemented, integrated services program for 12 months were functioning better in the community. There was a cost shifting from mental health to drug and alcohol services, as well as a one-third increase in the total costs of care by the end of the first year of treatment. Program implementation issues are described and the clinical management implications for more effectively serving dually diagnosed consumers through integrated treatment programs are discussed.

Entities:  

Mesh:

Year:  2000        PMID: 10932443     DOI: 10.1007/bf02291741

Source DB:  PubMed          Journal:  J Behav Health Serv Res        ISSN: 1094-3412            Impact factor:   1.505


  13 in total

1.  The reliability and validity of the SAS-SMI.

Authors:  K M Wieduwilt; J M Jerrell
Journal:  J Psychiatr Res       Date:  1999 Mar-Apr       Impact factor: 4.791

2.  The Chemical Use, Abuse, and Dependence Scale (CUAD). Rationale, reliability, and validity.

Authors:  M P McGovern; D H Morrison
Journal:  J Subst Abuse Treat       Date:  1992

3.  Combining social skills training and assertive case management: the social and independent living skills program of the Brentwood Veterans Affairs Medical Center.

Authors:  J V Vaccaro; R P Liberman; C J Wallace; G Blackwell
Journal:  New Dir Ment Health Serv       Date:  1992

4.  Analysis of three interventions for substance abuse treatment of severely mentally ill people.

Authors:  M S Ridgely; J M Jerrell
Journal:  Community Ment Health J       Date:  1996-12

5.  An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults.

Authors:  M A Burnam; S C Morton; E A McGlynn; L P Petersen; B M Stecher; C Hayes; J V Vaccaro
Journal:  J Addict Dis       Date:  1995

6.  Selecting a rating scale for evaluating services to the chronically mentally ill.

Authors:  R S Green; E J Gracely
Journal:  Community Ment Health J       Date:  1987

7.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

Authors:  L N Robins; J E Helzer; J Croughan; K S Ratcliff
Journal:  Arch Gen Psychiatry       Date:  1981-04

8.  Outpatient treatment of adults with coexisting substance use and mental disorders.

Authors:  M Hanson; T H Kramer; W Gross
Journal:  J Subst Abuse Treat       Date:  1990

9.  Toward cost-effective care for persons with dual diagnoses.

Authors:  J M Jerrell
Journal:  J Ment Health Adm       Date:  1996

Review 10.  Barriers to the care of persons with dual diagnoses: organizational and financing issues.

Authors:  M S Ridgely; H H Goldman; M Willenbring
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

View more
  10 in total

1.  An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program.

Authors:  Kevin W Chen; Annie N Banducci; Leila Guller; Richard J Macatee; Anna Lavelle; Stacey B Daughters; C W Lejuez
Journal:  Drug Alcohol Depend       Date:  2011-04-22       Impact factor: 4.492

2.  Treatment services and service delivery models for dually diagnosed clients: variations across mental health and substance abuse providers.

Authors:  Virginia Gil-Rivas; Christine E Grella
Journal:  Community Ment Health J       Date:  2005-06

3.  Using information technology to evaluate the detection of co-occurring substance use disorders amongst patients in a state mental health system: implications for co-occurring disorder state initiatives.

Authors:  Frederick Y Huang; Douglas M Ziedonis; Hsou Mei Hu; Anna Kline
Journal:  Community Ment Health J       Date:  2007-08-10

4.  Substance use, mental illness and violence: the co-occurrence of problem behaviors among young adults.

Authors:  Richard A Van Dorn; James Herbert Williams; Melissa Del-Colle; J David Hawkins
Journal:  J Behav Health Serv Res       Date:  2008-12-17       Impact factor: 1.505

5.  The relationship between outpatient mental health treatment and subsequent mental health symptoms and disorders in young adults.

Authors:  Richard A Van Dorn; Rick Kosterman; James Herbert Williams; Kristen Chandler; M Scott Young; Richard F Catalano; J David Hawkins
Journal:  Adm Policy Ment Health       Date:  2010-11

6.  Dropout Rates in Psychosocial Interventions for People With Both Severe Mental Illness and Substance Misuse: A Systematic Review and Meta-Analysis.

Authors:  Marianne Bouchard; Tania Lecomte; Briana Cloutier; Jessica Herrera-Roberge; Stéphane Potvin
Journal:  Front Psychiatry       Date:  2022-05-12       Impact factor: 5.435

7.  Clinical characteristics as a function of referral status among substance users in residential treatment.

Authors:  Anne N Banducci; Jennifer Dahne; Jessica F Magidson; Kevin Chen; Stacey B Daughters; C W Lejuez
Journal:  Addict Behav       Date:  2012-12-24       Impact factor: 3.913

8.  A comparison of schizophrenic patients with or without coexisting substance use disorder.

Authors:  Coreen Farris; Christiane Brems; Mark E Johnson; Rebecca Wells; Randall Burns; Nicholas Kletti
Journal:  Psychiatr Q       Date:  2003

9.  Perceptions of mental health and substance abuse program administrators and staff on service delivery to persons with co-occurring substance abuse and mental disorders.

Authors:  Christine E Grella; Virginia Gil-Rivas; Leslie Cooper
Journal:  J Behav Health Serv Res       Date:  2004 Jan-Mar       Impact factor: 1.505

10.  Psychosocial interventions for people with both severe mental illness and substance misuse.

Authors:  Glenn E Hunt; Nandi Siegfried; Kirsten Morley; Carrie Brooke-Sumner; Michelle Cleary
Journal:  Cochrane Database Syst Rev       Date:  2019-12-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.